Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms

Cell Res. 2021 May;31(5):597-600. doi: 10.1038/s41422-021-00497-7. Epub 2021 Mar 29.

Yao Sun^#¹, Lei Wang^#^{1

2}, Rui Feng^#^{1

2}, Nan Wang^#^{1

2}, Yuxi Wang^#³, Dandan Zhu^#¹, Xiaorui Xing¹, Peng Yang^{1

2}, Yanjun Zhang⁴, Weimin Li⁵, Xiangxi Wang^{6

7

8}

¹ CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
² University of Chinese Academy of Sciences, Beijing, 100049, China.
³ Department of Respiratory and Critical Care Medicine, West China Medical School/West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
⁴ Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, 310000, China. yjzhang@cdc.zj.cn.
⁵ Department of Respiratory and Critical Care Medicine, West China Medical School/West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. weimi003@scu.edu.cn.
⁶ CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China. xiangxi@ibp.ac.cn.
⁷ University of Chinese Academy of Sciences, Beijing, 100049, China. xiangxi@ibp.ac.cn.
⁸ Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, Guangdong, 510200, China. xiangxi@ibp.ac.cn.

^# Contributed equally.

No abstract available

Publication types